Adagio Medical Revenue and Competitors

Location

$56.1M

Total Funding

Estimated Revenue & Valuation

  • Adagio Medical's estimated annual revenue is currently $19.6M per year.(i)
  • Adagio Medical's estimated revenue per employee is $251,000
  • Adagio Medical's total funding is $56.1M.

Employee Data

  • Adagio Medical has 78 Employees.(i)
  • Adagio Medical grew their employee count by 16% last year.

Adagio Medical's People

NameTitleEmail/Phone
1
CEO & PresidentReveal Email/Phone
2
VP, Global Marketing and Product ManagementReveal Email/Phone
3
VP Clinical AffairsReveal Email/Phone
4
Director OperationsReveal Email/Phone
5
Chief Operating OfficerReveal Email/Phone
6
Chief Technical OfficerReveal Email/Phone
7
Chief Compliance Officer (CCO)Reveal Email/Phone
8
Director, Global Commercial Marketing - EuropeReveal Email/Phone
9
Chief Financial OfficerReveal Email/Phone
10
Account Manager UK & IrelandReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$20.3M817%N/AN/A
#2
$8.5M346%N/AN/A
#3
$4.5M18-10%N/AN/A
#4
$8M32-6%N/AN/A
#5
$5.3M210%N/AN/A
#6
$54.2M2169%N/AN/A
#7
$12M48N/AN/AN/A
#8
$10M405%N/AN/A
#9
$30.1M12022%N/AN/A
#10
$14.1M562%N/AN/A
Add Company

What Is Adagio Medical?

Adagio Medical, Inc. is a privately held company located in Laguna Hills, California developing innovative cryoablation technologies that create continuous, linear, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter and ventricular tachycardia. Adagio Medical, Inc. is a Fjord Ventures portfolio company. For additional information please visit https://www.adagiomedical.com or send an email to info@adagiomedical.com.

keywords:N/A

$56.1M

Total Funding

78

Number of Employees

$19.6M

Revenue (est)

16%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Adagio Medical News

2022-03-30 - The Petri Dish: Adagio says its antibody works against ...

Adagio now plans to ask the FDA for emergency use authorization of the medicine. Adagio has been plagued by uncertainty around the...

2020-11-16 - Adagio Medical Raises $42.5M In Series E Funding

Adagio Medical, Inc., a Laguna Hills, Calif.-based provider of treatments for atrial fibrillation (AF) and ventricular tachycardia (VT), and developer of the Continuous Lesion Ablation System (iCLAS™), closed a $42.5m Series E equity financing. Backers included new investors ArrowMark Partners, ...

2020-11-12 - Adagio Medical Raises $42.5 Million In Series E Financing USA - English España - español Deutschland - Deutsch France - Français

LAGUNA HILLS, Calif., Nov. 12, 2020 /PRNewswire/ -- Adagio Medical, Inc., a leading innovator for the treatment of atrial fibrillation (AF) and ventricular tachycardia (VT), and developer of the intelligent Continuous Lesion Ablation System (iCLAS™), today announced that it has closed a $42.5 ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$21.3M7910%N/A
#2
$21.6M8048%N/A
#3
$20.7M91N/AN/A
#4
$24.8M926%N/A
#5
$13.5M93-15%$3.4M